Reimagining Medical Affairs: Creating Value as Stakeholders, Commercial Models, and Therapies Evolve

This white paper discusses the evolution of medical affairs from a nascent function aimed primarily at educating healthcare professionals on the science behind life sciences products, to an integrated business unit engaged in two-way relationship building with a growing number of stakeholders. As the sophistication of medical affairs grows, the department’s foundation of business processes and technology solutions must also change – enabling medical affairs to meaningfully grow life science business.

This paper outlines a path towards a medical affairs organization that delivers focused clinical, social, and economic value throughout the product lifecycle.

Published by: Veeva